Podcasts about sequels

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

00:00:00 - Start00:04:38 - The Best Video Game Sequel Bracket00:16:27 - Top 3200:47:15 - Ads01:14:02 - Top 1601:25:00 - Top 801:33:44 - Final 4 Learn more about your ad choices. Visit megaphone.fm/adchoices

00:00:00 - Start00:04:38 - The Best Video Game Sequel Bracket00:16:27 - Top 3200:47:15 - Ads01:14:02 - Top 1601:25:00 - Top 801:33:44 - Final 4 Learn more about your ad choices. Visit megaphone.fm/adchoices

00:00:00 - Start00:04:38 - The Best Video Game Sequel Bracket00:16:27 - Top 3200:47:15 - Ads01:14:02 - Top 1601:25:00 - Top 801:33:44 - Final 4 Learn more about your ad choices. Visit megaphone.fm/adchoices

Special guest Kevin Darwish joins us this week to talk about his time on the set of The Cutting Edge: Chasing The Dream! Star ratings help us build our audience! Please rate/review/subscribe to us on Spotify, Apple Podcasts or wherever you listen, and share us with your friends...in bed! Email us at sequelrights@gmail.com with feedback or suggestions on future franchises!

Jim Hill and Drew Taylor are back together after Drew's birthday escape to Palm Springs, and they've got plenty of animation news to talk about. Pixar has its biggest ever box office for an original film opening, Pete Docter's Wall Street Journal interview takes an odd turn but at least they have a musical on the way, and of course there are the Old Spice marketing tie-ins to the upcoming Super Mario Galaxy movie that want you to smell like Bowser. HIGHLIGHTS • Disney Legend Floyd Norman's screening and Q&A at the Smithsonian National Museum of African American History and Culture in Washington DC has been postponed with no rescheduled date available as of yet • Hoppers has the best opening for a Pixar original film yet with an 88 million dollar worldwide gross • The first 40,000 fans through the gates on March 31st at the L.A. Dodgers game against the Cleveland Guardians will get an exclusive Yoshi bobblehead • Drew drops an exclusive story about the upcoming sequel to The Wild Robot • Cartoon Lagoon has a new film, Kindred Spirits, coming in 2028  • Jim and Drew discuss Pete Docter's recent interview with the Wall Street Journal and the reactions to it HOSTS • Jim Hill - IG: @JimHillMedia | X: @JimHillMedia | Website: JimHillMedia.com• Drew Taylor - IG: @drewtailored | X: @DrewTailored | Website: drewtaylor.work FOLLOW • Facebook: JimHillMediaNews• Instagram: JimHillMedia• TikTok: JimHillMedia SUPPORT Support the show and access bonus episodes and additional content at Patreon.com/JimHillMedia. PRODUCTION CREDITS Edited by Dave GreyProduced by Eric Hersey - Strong Minded Agency SPONSOR Unlock MagicPlanning a Disney or Universal trip in 2026? Unlock Magic helps you secure the very best deals on theme park tickets, with expert support from people who truly know the parks. Visit unlockedmagic.com to start planning your next adventure. If you would like to sponsor a show on the Jim Hill Media Podcast Network, reach out today. Learn more about your ad choices. Visit megaphone.fm/adchoices

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Stem Cell Islet Therapy Partnership, "Lyla's Law" Type 1 Testing Debate, Patient-Led Insulin Dosing for Gestational Diabetes, $3 Semaglutide Manufacturing, FDA GLP-1 Compounding Crackdown Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  transcript with links:  Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. I am definitely feeling better – that lingering cold is gone – but whew still recovering from non stop travel for the past five weeks. I have a great strech of time her at home, then going to Vegas for Brekathorugh T1D at the end of the month and we have two club 1921 events in April – Atlanta and Philly. Before we jump into the news – I need your community commercials! These have been a lot of fun, I announced them late last year – your voice on the show. All the instructions it's very easy in the show notes. Okay.. our top story this week: XX A biotech company developing stem-cell treatments for type 1 diabetes has announced a new research partnership aimed at improving the survival of transplanted insulin-producing cells. NewcelX, a clinical-stage company based in Switzerland, said it will work with Eledon Pharmaceuticals to study a combination approach. The goal is to help transplanted cells survive longer in the body by reducing the immune response that often leads to transplant rejection. If successful, the strategy could support longer-lasting islet cell replacement and move the therapy closer to becoming a functional treatment for people with type 1 diabetes. However, the companies have not yet released any safety or effectiveness data on the combination treatment, and financial details of the partnership were not disclosed. The research agreement is focused on exploring whether combining stem-cell-derived islets with targeted immune therapy can lead to longer-lasting cell transplants and improved outcomes for people with type 1 diabetes. https://www.stocktitan.net/news/ELDN/newcel-x-announces-strategic-collaboration-with-eledon-d10l1vqdofls.html XX Debate this week in the UK on whether testing for type 1 diabetes should become mandatory when children present with symptoms. The Westminster Hall debate, scheduled for 9 March, will consider calls for routine testing of babies, toddlers and young children who show signs associated with the condition. It follows a petition backing the move, dubbed 'Lyla's Law', which passed 121,000 signatures in December 2025. The campaign was launched by John Story after his two-year-old daughter, Lyla, died from diabetic ketoacidosis (DKA) on 3 May 2025, 16 hours after being diagnosed with tonsillitis. https://www.nursinginpractice.com/clinical/diabetes-and-endocrinology/diabetes-community-urged-to-call-on-mps-to-attend-lylas-law-debate/ XX     A new study suggests that people with gestational diabetes who adjust their own insulin doses may reach healthy blood sugar levels faster than those whose doses are adjusted by clinicians. Half of the participants were assigned to adjust their own insulin doses using a simple rule: increase the dose by two units if fasting blood glucose was above 95 mg/dL, decrease it by two units if it dropped below 70 mg/dL, and keep the same dose if levels fell in between. The other half had their insulin adjusted by clinicians through weekly reviews. By the end of pregnancy, both groups had similar average fasting glucose levels before delivery: about 89 mg/dL in the patient-led group and 90 mg/dL in the clinician-led group. However, those adjusting their own insulin reached their blood sugar targets more quickly, averaging 1.8 weeks compared with 2.5 weeks for those managed by clinicians. The study also found lower risks of certain complications among the patient-led group. https://www.medscape.com/viewarticle/self-insulin-dosing-leads-control-gestational-diabetes-2026a1000729 XX   A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low and middle-income countries.   Semaglutide, the active molecule in Novo Nordisk's Ozempic and Wegovy will lose patent protection in countries such as Brazil, China, and India later this month, and researchers identified 150 countries where it was never patented. These researchers estimated it will cost as little as $3 to produce a month's supply of semaglutide, which in its branded form sells for around $200 a month in the United States. Another of the study's authors, Professor Francois Venter at the University of Witwatersrand in South Africa, said drugs to treat HIV, TB, malaria, and hepatitis are now available at prices close to production costs but still sufficient for generic manufacturers to operate. https://www.sciencealert.com/weight-loss-drugs-could-cost-just-3-a-month-to-make-as-patents-end XX Here in the US the FDA is stepping up its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting telehealth companies it says make "false or misleading" claims about compounded versions of popular obesity drugs. The FDA says Compounded drugs can be important for overcoming shortages or meeting unique patient needs—but compounders should not try to compound drugs in a way that circumvents FDA's approval process." https://www.fiercepharma.com/pharma/fda-ramps-crackdown-glp-1-drug-compounders-fresh-batch-30-warning-letters XX   Check your infusion sets for an issue: Unomedical, a subsidiary of Convatec and a supplier of insulin infusion sets to diabetes tech firms, has received a warning letter from the FDA. Inspectors raised concerns with leaking infusion sets, following a regulatory assessment of Unomedical's facility in Reynosa, Mexico, last summer. Unomedical supplies infusion sets to insulin pump makers including Medtronic, Tandem Diabetes Care and Beta Bionics. In a Feb. 3 statement, Convatec said the letter focuses on reporting procedures and quality protocols and does not place restrictions on producing, marketing or distributing any of Unomedical's products.  Unomedical told the FDA in its responses that it plans to conduct a retrospective review of complaints involving serious injury or death by January and conduct additional training on complaint handling by May.   https://www.medtechdive.com/news/fda-warns-insulin-infusion-set-maker-unomedical-over-leaks-mishandled-comp/813503/ XX Nearly four in ten people with type 2 diabetes do not take their medications as prescribed, according to a new research review published in Diabetologia in November 2025.   Researchers examined existing studies on medication adherence, including how often patients miss doses, why it happens, and what strategies may help. They estimated that about 38% of patients with type 2 diabetes are not fully adherent to their medications.   Adherence rates vary depending on the type of medication. About 63% to 68% of patients take oral glucose-lowering drugs as directed, while adherence drops to 43% to 54% for injectable GLP-1 medications and 41% to 64% for insulin.   Poor adherence can lead to serious consequences. One retrospective study cited in the review found that patients who consistently took their glucose-lowering medications had a 31% lower risk of hospitalization or emergency department visits.   The review also highlighted ways to improve adherence. Simplifying medication routines can help, such as using fixed-dose combination pills, which combine multiple drugs into a single tablet. Studies show these combinations are linked to better adherence and improved blood sugar control.   Pharmacists can also play an important role by providing education, reviewing medications, setting up reminders, and helping patients organize their treatment plans. The researchers noted that support should be tailored to each patient. Older adults may benefit from simpler systems and caregiver support, while younger patients may respond better to digital tools like app-based reminders.   The authors also found that measuring adherence is challenging and recommend using multiple methods, such as pharmacy records, patient interviews, and objective tests when possible.   Overall, the review concludes that personalized, multi-step approaches lasting at least three months are most effective in helping people with type 2 diabetes stay on track with their medications. https://www.pharmacytimes.com/view/type-2-diabetes-medication-adherence-rates-remain-low-and-pharmacists-can-help XX New clinical trial shows metformin does not directly reverse insulin resistance in people with type 1 diabetes. Instead, it lowers the total amount of insulin required to keep blood glucose levels within the recommended range. The findings, published in Nature Communications, challenge long-held assumptions about how metformin works in type 1 diabetes. The results may help physicians refine treatment strategies and reduce the daily demands placed on people who rely solely on insulin therapy. "Insulin resistance is a growing problem in type 1 diabetes. Not only does it make regulating blood sugar levels difficult, but it is an underappreciated risk factor for heart disease, which is one of the biggest causes of health complications and deaths in those with type 1 diabetes," says Dr. Jennifer Snaith, endocrinologist and co-lead of the study.   https://scitechdaily.com/groundbreaking-trial-reveals-unexpected-benefit-of-metformin-in-type-1-diabetes/   Tech news ahead, including updates from Sensonics, Dexcom & Tandem.. right after this…. Back ot the wnews.. XX Sensonics shares that it's secured FDA investigational device exemption (IDE) for its self-powered, battery-enabled Gemini sensor. It enrolled the first patients in the IDE trial and expects to complete that in the second half of 2026. Gemini builds on the implanted CGM to put the transmitter under the skin as well as the sensor. https://www.drugdeliverybusiness.com/senseonics-q4-2025-ide-gemini-cgm/ XX Medtronic Diabetes is now officially MiniMid, a stand alone public company. Medtronic  acquired MiniMed 25 years ago announed last May that it would spin its diabetes business off. In their statement the company points out that MiniMed is the only diabetes tech company to sell both insulin pumps and continuous glucose monitors.   https://www.investing.com/news/stock-market-news/medtronics-diabetes-unit-minimed-valued-at-53-billion-as-shares-fall-in-nasdaq-debut-4547518 XX Kevin Sayer heads back to Dexcom.. The former CEO is back in his position as executive chair of the Board, he'd stepped away for a medical leave. Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence. Sayer's return to the board comes just days after Dexcom announced a new board member. Last week, the company announced that it added Google SVP, Platforms and Devices, Rick Osterloh, to its board as well.     https://www.drugdeliverybusiness.com/kevin-sayer-returns-dexcom-board-chair/ SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM) announced the appointment of Rick Osterloh to its Board of Directors, effective today, according to a press release statement.   Osterloh serves as Senior Vice President, Platforms & Devices at Google, where he oversees Android, Google Play, Chrome, and Google's hardware portfolio including Pixel phones, Google Nest devices, and Fitbit wearables. He has held this position since 2016.   https://www.investing.com/news/company-news/dexcom-appoints-google-executive-rick-osterloh-to-board-93CH-4529662 XX Sequel Med Tech announced broad national availability of its twiist™ Automated Insulin Delivery (AID) System powered by Tidepool. After U.S. FDA clearance in 2024 and a controlled launch to optimize the twiist experience, the system is now fully available nationwide. The release says: Built on Sequel's proprietary iiSure™ Technology, the system enables earlier detection of delivery issues, alerting users to blockages up to nine times faster than other AID systems1, potentially reducing the risk of unexplained high glucose and giving you time to take action before experiencing severe high blood sugar or DKA2. Designed to expand access to automated insulin delivery, twiist is available through pharmacy channels with a flexible access model, XX Tandem Diabetes Care's Mobi automated insulin delivery system is now available with Android devices. In November, Tandem announced that it received FDA approval for the Android version of its Mobi mobile app. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software. At the time of the clearance, it said it would commence a limited rollout before the full launch — now underway — this year.   Tandem launched Mobi in the U.S. in February 2024. It initially received FDA clearance for people with diabetes ages six and up in July 2023. The system then received expanded clearance for pediatric indications in April 2024, then later won CE mark in May 2025.   Mobi features a 200-unit insulin cartridge and an on-pump button to provide an alternative to phone control for insulin boluses. It comes in at less than half the size of the flagship Tandem pump system, the t:slim X2 pump. Mobi can fit in a coin pocket, clip to clothing or go on the body with an adhesive sleeve. https://www.drugdeliverybusiness.com/tandem-diabetes-care-launches-mobi-android/

This week on SUNDAY WIRE returns with host Patrick Henningsen as we breakdown the first disastrous week of Trump & Israel's unprovoked war on Iran, effectively dragging America back 80 years into the past, and threatening what seems to be an inevitable descent towards WWIII. Later in the Overdrive segment, we're joined by teammates Bryan "Hesher" McClain, Adam "Ruckus" Clark, and Basil Valentine, for deeper comment and analysis on this week's earth-shaking geopolitical development. All this and more on this week's edition of Sunday Wire. Watch this episode here: https://www.youtube.com/watch?v=579nZHb0_V0  This month's featured music artists: The Real Anthem Band, Joseph Arthur, Peyoti for President, Peter Conway & Red Rumble, and Phil Zimmerman SUPPORT OUR MEDIA OUTLET HERE (https://21w.co/support)

"I don't remember nothing." - AlexFind Here Come the Sequels on Spotify and Apple Podcasts; we're also online at herecomethesequels.blogspot.com, available through email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠herecomethesequels@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, on Bluesky under Here Come the Sequels, and on ... X? @HCTSequels.

We've dug into the podcast vault for the story of Star Trek's furniture.  Gene Roddenberry's Star Trek launched a franchise in 1966 and is still going strong 60 years later. Sequels, movies, toys, fan films - there's just no end to Star Trek's bright, progressive, optimistic future where Earth has transcended national and international politics. Something architecture fans may have missed, and we certainly did, is that Star Trek adapted midcentury Modern furniture for the set design, from the Bridge to the Conference Room, to the alien buildings on the planets they landed on.  Authors Dan Chavkin and Brian McGuire about talk their book: Star Trek: Designing the Final Frontier, The Untold Story of How Midcentury Modern Decor Shaped Our View of the Future. Later on, legendary singer Jennifer Warnes, who you've loved for I've Had the Time of my Life, Right Time of the Night, Up Where We Belong, and a vast treasure of songs with and by Leonard Cohen.

TIME STAMPS:00:00:01 Community Guest Intros00:00:35 DOOM The Dark Ages DLC is "Freaking Huge and Is Basically A Sequel" Says Director!00:42:00 ICYMI—According to Shinobi602, we will be getting Starfield news sometime this month (March).01:09:00 There has been A LOT of chatter Re: bringing back Xbox. Watching the community react has been very interesting.02:17:00 Panel Outros and Special Message to the Community!

From Sunday 8 March 2026 Dr. Tim Beougher continues the sermon series from The Book of Acts with a message titled "The Sequel" Acts 1:1-5fbcmw.org

It's time for another Mind Gap Podcast! This week, Doug and Justin dive into a "what would you do" based on another Reddit story, this one involving a student who accidentally submitted erotic fan fiction to their professor instead of their term paper. Doug then tells Justin a tale about an unwanted timeshare pitch that happened at a hotel while spending a weekend in the Wisconsin Dells. Needless to say, Practical Doug and Justice Doug were very much on edge. The dorks finally make it to the main topic, when a sequel accidentally rewrites the moral of the original. They discuss examples like Jurassic Park, Rocky, Rambo, Wall Street, Star Wars, and X-Men.   Things are wrapped up with a game of Tagline Trivia, where Justin reads three taglines for a movie and Doug has to pick which one is the real one.   Check out our YouTube channel! Be sure to like and subscribe for this content as well as episode highlights, Doug Watches Awkward Videos, Justin Plays Video games, and more!   We have MERCH now!   Follow us on all of our social medias and other platforms!  

This week, The Good, The Bad, and The Sequel dives into Detective Knight: Redemption, the second entry in the Bruce Willis-led action trilogy that blends Christmas chaos, prison breaks, and a surprisingly wild storyline.Part action thriller, part holiday crime movie, and fully packed with over-the-top moments, Detective Knight: Redemption swings big with its twists, characters, and nonstop “wait… what?” moments.We dig into everything, including:

"I don't need friends. I need fans."Sequel month 2026 is kicking off with a title chosen by the Patreon supporters, SCREAM 4. This week, The Wives Colangelo are heading back to Woodsboro to dissect the second generation of Ghostface victims and speculate why so many people despise this entry (despite it being Harmony's favorite). It's gonna be a scream, baby!--------Become a Patron! https://www.patreon.com/thisendsatprom--------MONTHLY SPOTLIGHTResources for Trans Youth in Kansas: https://southernequality.org/ks/--------Social Media Plugs@ThisEndsAtProm@BJColangelo@HarmonyColangelo----------Logo Design: Haley Doodles @HaleyDoodleDoTheme Song: The Sonder Bombs 'Title': https://thesonderbombs.bandcamp.com/

Nick Schager is the Entertainment Critic for the Daily Beast and a longstanding CGP regular. This week Nick reviews The Bride (theaters), Vladimir (Netflix) and Rooster (HBO). The Christopher Gabriel Program ----------------------------------------------------------- Please Like, Comment and Follow 'The Christopher Gabriel Program' on all platforms: The Christopher Gabriel Program is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts. --- The Christopher Gabriel Program | Website | Facebook | X | Instagram | --- Everything KMJ KMJNOW App | Podcasts | Facebook | X | Instagram See omnystudio.com/listener for privacy information.

M3GAN is back! Our favorite killer robot is back for round two - Terminator 2 style. Brain implants to emotions to best-seller-list manipulation, we chat about these and MUCH more. Email us: KillerFunPodcast@gmail.comFollow us on Facebook: fb.me/KillerFunPodcastAll the Tweets, er, POSTS: https://x.com/KillerFunPodInstagram: killerfunpodcast

Welcome to another episode of Death Don't Do Fiction, the AIPT Movies podcast! The podcast about the enduring legacy of our favorite movies! This February we're continuing our new “Fast February” series, where we cover the movies that made Vin Diesel a star and taught the world to live their lives one quarter mile at a time, The Fast & Furious franchise! In this week's episode, Alex, Tim, and returning guest Bill Mueller discuss 2003's awkward attempt to recapture the magic of the surprisingly successful first movie, 2 Fast 2 Furious! An incredible title! Those silly visor hats! Pepsi and NOS product placement! Trying to pick up girls during a dangerous undercover mission! A Sound Designer-approved audio mix! Loud, somewhat gaudy visuals thanks to that clumsy early thousands aesthetic! A possible influence on the Wachowskis' Speed Racer movie! A larger budget but a less tangible story with somehow even cringier lines! A third act you'll barely remember! The introduction of characters who would go on to be staples of the series! John Singleton trying his hand at directing a silly blockbuster! Race obstacles that would lead to expensive automotive repairs! A great car jump stunt that's wasted due to poor editing and unnecessary visual effects! A cast that includes a returning Paul Walker, James Remar, Eva Mendes, a pre-Yellowstone Cole Hauser, Mark Boone Junior, Devon Aoki, Ludacris, and Tyrese Gibson starting out as somewhat of a Dom Toretto wannabe before finding his character as the movie goes on! The entry of the series with possibly the least sense of "family," you never realized you could miss Vin Diesel so much! In addition, Alex shares his spoiler-free thoughts on Crime 101, Psycho Killer, and the original Hunger Games quadrilogy! You can find Death Don't Do Fiction on Apple Podcasts, Spotify, or wherever you get your podcasts. As always, if you enjoy the podcast, be sure to leave us a positive rating, subscribe to the show, and tell your friends! The Death Don't Do Fiction podcast brings you the latest in movie news, reviews, and more! Hosted by supposed “industry vets,” Alex Harris and Tim Gardiner, the show gives you a peek behind the scenes from two filmmakers with oddly nonexistent filmographies. You can find Alex on Twitter, Bluesky, or Letterboxd @actionharris. This episode's guest, Bill Mueller, can be found on Bluesky. Tim can't be found on social media because he doesn't exist. If you have any questions or suggestions for the Death Don't Do Fiction crew, they can be reached at aiptmoviespod@gmail.com, or you can find them on Twitter or Instagram @aiptmoviespod. Theme song is “We Got it Goin On” by Cobra Man.

Here's your first warning: Beneath the Trees Where Nobody Sees: Rite of Spring spoilers ahead! Patrick Horvath returns for a full spoilers breakdown of the sequel series to IDW Publishing's smash hit. Together, we consider the cartoonist's joyous relationship with beauty and horror, where Monica the Duck finds herself in the last panels of the final issue, and why we were so wrong about George the last time we spoke with Horvath. Or, were we? Sequels are a terrible, stressful thing to attempt, but we all know why they happen. Beneath the Trees Where Nobody Sees was too damn successful to be left alone, and thankfully, Horvath, the book's shepherd, returned to his drawing table with passion and a mission for his characters. Rite of Spring is not only better than the original series, but it must also be considered as one of the best comic book sequels of all time. And it's because it might leave certain readers fur-ious (sorry, not sorry) regarding where Horvath leaves (or drags) certain characters. Patrick Horvath is not afraid to hurt his comic book kids. However, as we discuss, there is as much love and beauty in his series as there is grotesque horror. Beneath the Trees Where Nobody Sees: Rite of Spring is a deeply human book, and as such, it stirs profound feelings within the reader. Also, yo, another sequel is coming. What can we expect? We put that question to Horvath, too. All six issues of Beneath the Trees Where Nobody Sees: Rite of Spring are out now from IDW Publishing. Continue this conversation with Patrick Horvath by following him on Bluesky, Instagram, and his Website. This Week's Sponsors The Future is Calling! 2000 AD is the Galaxy's Greatest Comic, with new issues published every single week! Every 32-page issue of 2000 AD brings you the best in sci-fi and horror, featuring characters like Judge Dredd, Rogue Trooper, and more. Get a print subscription to 2000 AD and it'll arrive to your mailbox every week - and your first issue is free! Or subscribe digitally, and you can download DRM-free copies of each issue for only $9 a month. That's 128 pages of incredible comics every month for less than $10! Head to 2000AD.com and click on ‘subscribe' now – or download the 2000 AD app and start reading today! Other Relevant Links to This Week's Episode: Subscribe to the Comic Book Couples Counseling YouTube Channel Watch The Stacks, Comic Creators Name Their Favorite Comics CBCC on The Beat: Why Comics Needs Its Own Criterion Closet The Ultimate Beneath the Trees Where Nobody Sees Spoiler-Filled Episode Patrick Horvath at NYCC 2024 Our First Beneath the Trees Where Nobody Sees Episode AIPT reports on The Stacks CBCC on Dollar Bin Bandits CBCC on Pop Culture Squad Support Your Local Comic Shop: Secret Identity Comics in Chester, England Comic Book Club: My Boyfriend is a Bear at Meanwhile...Coffee in Herndon, Virginia, on 2/1 at 3:30 PM Comic Book Film Club: The Phantom at the Alamo Drafthouse Winchester on 3/15 Final Round of Plugs (PHEW): Support the Podcast by Joining OUR PATREON COMMUNITY. And, of course, follow Comic Book Couples Counseling on Facebook, on Instagram, and on Bluesky @CBCCPodcast, and you can follow hosts Brad Gullickson @MouthDork & Lisa Gullickson @sidewalksiren. Send us your Words of Affirmation by leaving us a 5-star Review on Apple Podcasts. Continue your conversation with CBCC by hopping over to our website, where we have reviews, essays, and numerous interviews with comic book creators. Podcast logo by Jesse Lonergan and Hassan Otsmane-Elhaou.

Watch the video version of this episode, listen to all of our episodes ad-free and new episodes early by supporting the show on Patreon (and catch our free livestreams there, too!): https://www.patreon.com/solidlisten For our Jesus Episode (33), Rob and Molls talk about terribly straight to DVD sequels for hugely popular movies (Disney is one of the greatest offenders in the category, but wait until you hear what they've done with the Land Before Time and Ace Ventura) before indulging in a good ol' fashioned bitch sesh about this season of The Traitors. Spoilers are in the second half, of course, but if you have managed to avoid the results of this season thus far, you probably aren't listening to this at all! Watch our new Survivor podcast with our friend Jessica Shelton on YouTube: https://youtu.be/mTD0k-EHbR4?si=Myj_ASlJuLfzhsx5 Listen to Plz Survive anywhere you get podcasts: https://pod.link/1879415350 Follow Rob: https://www.robschulte.com/ Follow Molly: https://mollymcaleer.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Grab yourself a Little Latte and sit back and enjoy our check-in on the Scream Franchise with the brand new film, Scream 7!! Star ratings help us build our audience! Please rate/review/subscribe to us on Spotify, Apple Podcasts or wherever you listen, and share us with your friend who used to work at Google and now just kills people for fun! Email us at sequelrights@gmail.com with feedback or suggestions on future franchises!

When you finish Book 1 of a brand-new fantasy series, there's always that moment of hesitation…You loved the characters.You enjoyed the world.The story hooked you.But then comes Book 2 — and that's where a series either levels up… or lets you down.In today's episode of Fantasy for the Ages, Jim reviews The Way of Stones by Ryan Lanz, the second installment in the Red Kingdom series, following the enjoyable first book The Silver Crystal. Does Lanz build on what worked in the first novel? Do the characters continue to shine? And does the story deepen the mysteries of this growing fantasy world?In this spoiler-lite review, Jim discusses:• What makes The Way of Stones an engaging sequel• Why the characters continue to be a highlight of the series• How the pacing and short chapters keep the story moving• The expanding magic system and plot mysteries• A few elements that may not work for every reader• Whether the series is worth continuing into Books 3–5If you enjoy accessible epic fantasy, strong character-driven storytelling, and intriguing series mysteries, this might be a series worth adding to your TBR.Have you read The Way of Stones or the Red Kingdom series yet? Share your thoughts in the comments!If you enjoy fantasy book reviews, be sure to like the video, subscribe to the channel, and check out our Patreon to help support Fantasy for the Ages: patreon.com/FantasyForTheAges#FantasyBooks #BookReview #EpicFantasy #RyanLanz #TheWayOfStones #RedKingdom #FantasyForTheAges #FantasySeries #BookTube #SpeculativeFictionWant to purchase books/media mentioned in this episode?The Silver Crystal: https://t.ly/16YPLThe Way of Stones: https://t.ly/aZF52Ways to connect with us:Follow Jim/Father on Goodreads: https://www.goodreads.com/user/show/13848336-jim-scriven Join us on Discord: https://discord.gg/jMWyVJ6qKk Follow us on "X": @Fantasy4theAges Follow us on Blue Sky: @fantasy4theages.bsky.socialFollow us on Instagram: fantasy_for_the_ages Follow us on Mastodon: @FantasyForTheAges@nerdculture.de Email us: FantasyForTheAges@gmail.com Check out our merch: https://www.newcreationsbyjen.com/collections/fantasyfortheagesJim's Microphone: Blue Yeti https://tinyurl.com/3shpvhb4 Jim's Camera: Razer Kito Pro https://tinyurl.com/c873tc2n 0:00 - Opening2:10 - Book Details3:02 - Why Jim Read This3:39 - Spoiler-Lite Summary4:57 - Seven Reasons You May Enjoy This Book8:14 - Three Reasons It Might Not Work for Some Readers9:59 - Jim's Final Thoughts11:33 - Closing & Wrap-Up————————————————————————————Music and video elements licensed under Envato Elements:https://elements.envato.com/

On this episode of NOW SLAYING, Colton & Rowan sharpen their knives and cut into SCREAM 7! Can a seventh entry still give us exciting kills? Are the returning fan-favourite characters enough to distract us from the no shows? And, in a world consumed by reboots, requels, and A.I. slop, would deepfake versions of us have given this a more favourable review? Tune in to find out if we gave this film a NAY, OKAY, YAY, or SLAY!CHAPTERS:Theme/Intro (00:00:00)Trailer (00:07:19)Synopsis (00:07:49)Review (SPOILER FREE) (00:08:04)Review (SPOILERS) (00:27:15)Rating (00:56:18)Promotions/Outro (01:00:25)Follow us on all social media:FacebookTwitterInstagramTumblrYoutubeTikTokSlasherThreadsBlueskyWant some official Merch?!SHOP HERE!*Intro Music by Rowan Fraser (IG: @biggiehauls)*Support the showSupport the show

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week on the podcast, the James Cameron movies will continue until morale improves.Find Here Come the Sequels on Spotify and Apple Podcasts; we're also online at herecomethesequels.blogspot.com, available through email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠herecomethesequels@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, on Bluesky under Here Come the Sequels, and on ... X? @HCTSequels.

Welcome Back! Your go-to for the latest in movies, TV shows, and video games news, reviews, and rants all in one place! & this week we are reviewing "SCREAM 7" ==========================Lets Connect

Nobody can possibly imagine this series going on after we saw Hannibal rise but that's exactly what we're doing because it's time to pitch sequels to the Hannibal series! You'll hear which of us is going the Godfather II route, which of us went the bring back the cast no matter how old they are route, and whether or not we like and our can remember each other's titles. Enjoy! Thanks to our monthly supporters Matt and Vicki S Kate Lampe Daniel Prudhoe Andrew Pangle Steve Weiss Matthew Aldrich Edward Lankford Heather Sahami

Listen now: This week's latest Bollywood news and entertainment updates.

SPECIAL GUEST - Gary Taylor Fletcher Learn more about your ad choices. Visit podcastchoices.com/adchoices

The lads discuss March.Has any podcast ever done 300 episodes? We're trying to figure this out. New music coming alongside THE FORCE AWAKENS?? What if... ★ Support this podcast on Patreon ★

Welcome to Sarlacc Digest

The fire chief in St. John's tells us that, after a series of punishing snowstorms, he and his crew worked overtime to help dig Newfoundlanders out -- and also helped deliver a new one.Canada's Minister of Artificial Intelligence meets with OpenAI over the company's failure to report disturbing posts by the Tumbler Ridge shooter to law enforcement. Four years after Russia's invasion of Ukraine, there is still no end in sight. We'll return to a guest who's working to honour Bucha's dead and to help the city move forward.A brand new American inter-agency task force may have helped Mexico track down El Mencho -- another indication of the increased militarization of the battle against the cartels. WWII historian tells us the story that stopped him in his tracks -- a story that ended with a 108-year-old Ontario woman being presented with a long-overdue wartime medal. During a soccer game in Turkey, a gull is felled mid-flight when it's smacked by a ball -- and saved when a player immediately begins CPR.As It Happens, the Tuesday Edition. Radio that tells the whole story -- from death to rebirdth.

We're back after a brief hiatus with the next film in the Cutting Edge series!! Special guest Lindsay LeMaire joins us for an episode that may have had us laughing more than any other. It's time to head to the Olympics yet again with The Cutting Edge: Going For The Gold! Star ratings help us build our audience! Please rate/review/subscribe to us on Spotify, Apple Podcasts or wherever you listen, and share us with your friend who writes soundalike songs for the movies! Email us at sequelrights@gmail.com with feedback or suggestions on future franchises!

We all know that the sequel is rarely as good as the original. And when the original was bad... Mike Maharrey has argued that current dynamics in the markets and the economy look a lot like they did in the years just before the 2008 financial crisis.  He's not alone.  JPMorgan CEO Jamie Dimon recently made the same argument.  In this episode of the Midweek Memo, Mike highlights the parallels between then and now in light of Dimon's analysis. He also covers the current dynamics in the platinum market.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: I'm just back from MNO DC and I'm exhausted. But it's the best kind of tired. We had an incredible time – hope you can join us in Nashville. With a reminder that we have our first Club 1921 in Nashville – that's our educational dinner series for HCPs and patient leaders. All the info is over at diabetes-connections.com events/     Okay.. our top story this week: XX An "immune system reset" eliminated Type 1, diabetes in mice in a study conducted at Stanford Medicine without immune suppressant medications. This was a combined transplant of blood stem cells and insulin-producing pancreatic islet cells from a donor whose immune profile did not match the recipient. The dual transplant approach both restored insulin production and retrained the immune system. For the full six months of the experiment, the animals did not need insulin injections or immune suppressive medications. Challenges remain using this approach to treat Type 1 diabetes. Pancreatic islets can be obtained only after death of the donor, and the blood stem cells must come from the same person as the islets. It is also unclear whether the number of islet cells typically isolated from one donor would be enough to reverse established Type 1 diabetes. But the researchers are working on solutions, which could include generating large numbers of islet cells in the laboratory from pluripotent human stem cells, or finding ways to increase the function and survival of transplanted donor islet cells. https://scitechdaily.com/stanford-scientists-cure-type-1-diabetes-in-mice-without-insulin-or-immune-suppression/ XX An electronic implant interlaced with islet cells is being looked at to treat type 1. Researchers at the University of Pennsylvania School of Medicine worked with engineers at Harvard University to combine stem-cell biology with soft electronics. They inserted an ultrathin, flexible mesh of conductive wires — thinner than a human hair — into developing pancreatic tissue. As the cells assembled into clusters, the mesh became woven through them. The electronics can record the faint electrical signals produced by the cells that control insulin release. They can also deliver small pulses of electricity back to the cells.   After several days, the cells began to behave more like mature islets. Their internal signalling shifted, neighbouring cells started working in concert and insulin release became stronger and better timed.  Very early on here – and the transplanted cells still need to be protected from being attacked by the immune system. https://www.thetimes.com/uk/science/article/first-cyborg-pancreas-implants-type-1-diabetes-nxkv8r0fp?gaa_at=eafs&gaa_n=AWEtsqeJYYUF9TMR-GgGUG92hPyog-ISeiqGIgdyaaIKKcpvhtoftGiUaaOtQeG0NWI%3D&gaa_ts=699c50d4&gaa_sig=w-PQ0ArosZSznYDSWEzt8aQg4WC0FF5ZFRt9NedO5sSTL2FyWzupH8eSG7RCy2S8TQnlHOeKCudANWm1MNI59w%3D%3D XX Katie Beth (hand) Eledon trial – aaron kowalski post linkedin. Last fall we told you about promising results from Eledon's drug to prevent islet transplantation rejection in type 1 diabetes. The first six patients no longer had to inject or infuse insulin.. the trials continue and this month one of the patients – Katie Beth Hand – began posting about her experiences one month in, on social media, she says she's off basal insulin already and in range 99 percent of the time. She is also encouraging people to learn more about support the islet act https://lnkd.in/e8pQ7_Y7 XX This is a bill introduced last November which would change the wording on pancreatic cell transplants. The problem is that islets are classified as drugs rather than organs, making transplantations difficult for medical teams and centers to preform due to accessibility. Insurance companies are also less likely to provide reimbursements for treatment, which can cost hundreds of thousands of dollars. The official Journal of The Transplantation Society estimates the cost at about $140,000. The bill went to the senate committee of Health, Education, Labor, and Pensions in early November. No other action has been taken since then. https://www.wtoc.com/2026/02/19/bluffton-family-advocates-islet-act-help-diabetic-son/ XX Big change for the obesity drug Zepbound – now available in the multi dose KwikPen. This is a month's worth of doses in a single pen.. and it's multi dose – you can adjust it. Cash-paying patients can get the multi-dose device, called KwikPen, on the company's direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level. Until now, you could only get zepbound in a single dose auto injector or a sing dose vial. In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device. The KwikPen is already used for other drugs, such as Lilly's popular diabetes medication, Mounjaro – which is the same medication as zepbound, they're both tirzepitide. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html   XX For years, researchers have observed that people who live at high elevations,  tend to develop diabetes less often than those at sea level. Although the trend was well documented, the biological explanation behind it was unclear. Scientists now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply. The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels. They then evaluated HypoxyStat, a drug recently developed in Jain's lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments. https://www.sciencedaily.com/releases/2026/02/260221060952.htm XX Watching this one closely – Portal Diabetes gets FDA breakthrough device designation for its implantable insulin pump system. This is a system that includes not just a device that's implanted into the abdomen, but also a new, temperature stable insulin. It will work with – quote – "modern" CGM technology with a fully closed loop - and aims to deliver a functional cure for type 1. While reports say Portal's system is the first in the US – there was an implantable pump developed and used by about 500 people worldwide, including about 100 in the US – by MiniMed. Medtronic bought the company and in 2007 they stopped that program. Portal Diabetes expects to begin clinical trials on its combination system around the fourth quarter of 2027. https://www.drugdeliverybusiness.com/portal-diabetes-fda-breakthrough-implantable-insulin-pump/ XX Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. That's the eversense cgm and twist pump. Sequel said its full launch with Eversense 365 makes twiist available with two compatible CGMs. twiist also pairs with the Abbott FreeStyle Libre 3 Plus sensor. Eversense 365, an implantable system, rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. https://www.drugdeliverybusiness.com/sequel-senseonics-full-launch-twiist-eversense/ XX Right back with a Dexcom update, and a look at which type of diet reduces insulin use overall.. right after this: -- Back to the news.. Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don't take insulin. CEO Jake Leach told investors on Thursday that the company has been "sitting here waiting for a coverage decision" from the Centers for Medicare and Medicaid Services Dexcom started to see commercial coverage unlock for Type 2, non-insulin users toward the end of last year, Leach said. He expects broader Medicare coverage for that group would allow nearly 12 million people to access CGMs.     In the meantime, the American Diabetes Association updated its guidelines last year to recommend clinicians consider using CGMs for Type 2 diabetes when patients are taking glucose-lowering medications other than insulin. Leach said that real world data the company has been generating supports that decision, and that Dexcom has launched a registry for non-insulin users. https://www.medtechdive.com/news/dexcom-seeks-expanded-medicare-coverage-of-cgms-for-type-2-diabetes/812223/ XX Medtronic's separation of MiniMed is not yet complete.. but continues to move forward. The company has submitted their next pump – MiniMed Flex – to the FDA. This is a pump smaller than the 780G but uses the same reservoirs and infusion sets. It will also work with both the Simplera Sync and Instinct sensors. Medtronic also began a U.S. pivotal study for Vivera, its third-generation algorithm for automated insulin delivery. It also remains set to submit its MiniMed Fit patch pump system to the FDA by the coming fall. https://www.drugdeliverybusiness.com/medtronic-submits-minimed-flex-fda-q3/ XX A study modelling how genes may influence a child's body mass index over time has found that BMI at age 10 and overall growth rate between ages one and 18 might be important factors, as the two are more likely linked to diabetes, high cholesterol, and heart disease in later life. Nearly 66,000 BMI measurements from around 6,300 children and adolescents aged one to 18 were analysed to understand the role of genes.     "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit." https://www.ndtv.com/health/bmi-at-age-10-growth-rate-up-to-age-18-are-important-factors-for-diabetes-heart-disease-study-11125146 XX A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change. Researchers say the reduced insulin requirement likely reflects improved insulin sensitivity. The original 2024 study reported additional benefits from the vegan diet. Participants lost an average of 11 pounds and showed improvements in insulin sensitivity and glycemic control. Cholesterol levels and kidney function also improved among those following the plant-based plan. https://www.sciencedaily.com/releases/2026/02/260212234212.htm XX Interesting little tidbit from the Winter Olympic Games.. the World Anti-Doping Agency (WADA) was monitoring GLP drug use. An advisory group that makes recommendations about WADA's list of prohibited substances discussed the status of GLP-1 medications, and added semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) to its monitoring program That means patterns of use of these drugs will be tracked both in and out of competition.  The finding will be used to make recommendations about whether GLP-1 agonists should be added to the prohibited list, the spokesperson explained. While GLP-1 drug use is not currently prohibited, that could change before the next Summer Olympic Games in Los Angeles in 2028, he noted. https://www.medpagetoday.com/popmedicine/cultureclinic/119770 XX That's it for in the news!

A little halfway through the season, time to talk about everything thats airing, with our Mid-season check in! SPOILERS AHEADSocials/Discord - https://linktr.ee/whatdoyousayanime0:00 - Intro2:40 - Journal with Witch9:16 - Shiboyugi: Playing Death Games15:12 - Fate/Strange Fake18:00 - You and I are Polar Opposites21:54 - Tamon's B-Side26:23 - Invisible Man and His Soon to be Wife30:46 - In the Clear Moonlit Dusk34:05 - Demon King's Daughter is Too Kind36:40 - Sequels for later (Medalist S2 & Hell's Paradise S2)37:33 - Trigun Stargaze37:53 - Oshi no Ko S340:26 - Jujutsu Kaisen S342:04 - Golden Kamuy Final Season42:38 - Sentenced to be a Hero44:15 - Wash It All Away44:52 - Kaya-chan Isn't Scary45:22 - Frieren S2

It's time to unravel the mystery.Find Here Come the Sequels on Spotify and Apple Podcasts; we're also online at herecomethesequels.blogspot.com, available through email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠herecomethesequels@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, on Bluesky under Here Come the Sequels, and on ... X? @HCTSequels.

Episode Description: “Can a classic movie ever recapture its original magic—or is nostalgia the real star?”

Ten years after the original Mamma Mia! a sequel appeared... and Here We Go Again! Oh, and luckily for us, we watched them within just about 1 year of each other, give or take. We're back and discussing the jukebox musical sequel to 2008's Mamma Mia! with all its campy delights, hundreds of fires, flashbacks, ABBA, and Meryl Force Ghosts. Plus, the MouthGarf Report, and of course, I See What You Did There!Please give us a 5 star rating on Apple Podcasts! Want to ask us a question? Talk to us! Email debutbuddies@gmail.comListen to the archives of Kelly and Chelsea's awesome horror movie podcast, Never Show the Monster.Get some sci-fi from Spaceboy Books.Get down with Michael J. O'Connor and the Cold Family and check out his new compilation The Best of the Bad Years 2005 - 2025Next time: First Graffiti

We've donned our culturally inappropriate samurai gear to do battle with the 2007 sequel, Hannibal Rising. You'll hear how quickly we think this movie goes off the rails as it starts to build sympathy for the serial killing character we know as Hannibal Lecter, so many tangents about a myriad of things that have nothing to do with this sequel, and a disagreement about what we should be talking about at the end of this film as one of us has clearly given up wanting to talk about this sloppy mess of a movie. Thanks to our monthly supporters Matt and Vicki S Kate Lampe Daniel Prudhoe Andrew Pangle Steve Weiss Matthew Aldrich Edward Lankford Heather Sahami

With Resident Evil Requiem around the corner, the Access gang are chatting about brilliant sequels that somehow surpassed their incredible predecessors. Join us as we share our favourite sequels, and discuss what we think makes a great sequel. What are your favourite videogame sequels? Let us know in the comments!PlayStation Access is the official YouTube channel of PlayStation UK - a vibrant, welcoming community celebrating all things PlayStation. Join us for gaming livestreams, list features and in-depth coverage on all your favourite games. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Eric sits down with serial fitness entrepreneur Anthony Geisler to unpack his new venture, Sequel, why he's doubling down on longevity, and how he sees the future of fitness shifting toward healthspan, tech-enabled training, and democratized wellness for the masses.​ ✨ Key takeaways

#921. Arielle Kebbel has spent over two decades in Hollywood, but this conversation reveals the parts of her story she's never shared like this before. From booking Gilmore Girls just days after moving to Los Angeles at 17, to nearly landing iconic roles that could have changed the course of her career, Arielle opens up about the fear, pressure, and survival mindset that quietly drove her for years.She shares a deeply honest update on her relationship status, what it really takes to break your own patterns, and why choosing yourself can be both the hardest and most empowering decision you'll ever make. We talk about the emotional pull that led her to adopt her wild Mustang, Snow White, the unexpected role horses have played in her healing, potentially producing the long-anticipated John Tucker Must Die sequel, and stepping into her current meaningful role in I Can Only Imagine 2!This is a raw, vulnerable conversation about identity, timing, and what happens when you finally stop running from yourself.If you're LOVING this podcast, please follow and leave a rating and review below! PLUS, FOLLOW OUR PODCAST INSTAGRAM HERE!Thank you to our Sponsors! Check out these AMAZING deals!ASPCA Pet Insurance: To explore coverage, visit ASPCApetinsurance.com/VINE. Bombas: Head over to Bombas.com/VINE and use code VINE for 20% off your first purchase.Tonal: Right now, Tonal.com is offering OTV listeners $200 off your Tonal purchase with promo code VINE.Audible: Listen to Messy Love: Difficult Conversations for Deeper Connection now on Audible. Go to Audible.com/MessyLove to start listening today.Apartments.com: The Place to find a place!EPISODE HIGHLIGHTS: (5:01) — Arielle's honest relationship status update!(20:04) — The emotional story behind adopting her wild Mustang, Snow White(30:15) — Booking Gilmore Girls days after moving to L.A.(37:50) — Her fear around money, overworking & survival mode(45:55) — The truth about the John Tucker Must Die sequelSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn the 5 key elements every scene needs to move your story forward and keep readers turning pages.Scene structure doesn't have to be complicated. Sure, there are many methods out there, such as Story Grid's Five Commandments, Dwight Swain's Scene and Sequel, and James Scott Bell's LOCK system. And if you've tried learning from more than one method, it can feel like everyone's teaching something completely different. But the truth is, they're actually not. Because when you strip away the terminology, they're all pointing to the same core ideas.In this episode, I'm breaking down those five core elements—the ones hiding inside every scene structure method you've ever heard of. Once you understand what they are, you can stop guessing and start writing scenes that actually move your story forward.You'll hear me talk about things like:[05:18] Why your character needs a clear goal before the scene begins, and why it's so hard to fix later if you skip it.[07:01] What separates real conflict from obstacles, and why your scene antagonist needs their own agenda.[10:41] What actually creates a turning point in a scene, and why piling on tension alone won't get you there.[12:39] Why your POV character must be the one making a high-stakes decision, and the reason reader investment dips when someone else chooses for them. [15:55] The consequences that follow your character's decision and how their specific reaction creates momentum in your next scene.By the end of this episode, you'll have a clear framework you can apply to any scene you're writing or revising. And you can grab my free scene-structure guide from the links below to start applying it right away.

1. Super Bowl 2026 Recap, Turdy's Version (15:00) 2. Jake Paul Sobs as Fiancée Jutta Leerdam Wins Gold and Breaks Olympic Speedskating Record in Milan (PEOPLE) (33:34) 3. Taylor Frankie Paul Wonders If She's 'Worthy of Love' in First Promo for The Bachelorette Season 22 (PEOPLE) (37:34) 4. Marc Anthony says Beckham family feud is ‘hardly the truth' after getting dragged into drama (Page Six) (44:27) 5. Kim Kardashian Appears to Be Cheered on by Lewis Hamilton as She Attempts 'Titanic Challenge' with Sisters Khloé and Kylie (PEOPLE) (48:14) - Dear Toasters Advice Segment (55:38) The Toast with Jackie (@JackieOshry) and Claudia Oshry (@girlwithnojob) ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Toast Patreon ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Toast Merch ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Girl With No Job by Claudia Oshry ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Camper & The Counselor⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lean In Learn more about your ad choices. Visit megaphone.fm/adchoices